Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Taneja

Showing results (61-70 of 845) with videos related to

Pageof 85
Sort By:
The Journal of Urology|November 18, 2017
Re: Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerSamir S Taneja
The Journal of Urology|November 18, 2017
Re: Association between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerSamir S Taneja
The Journal of Urology|November 18, 2017
Re: Associations of Luminal and Basal Subtyping of Prostate Cancer with Prognosis and Response to Androgen Deprivation TherapySamir S Taneja
Reviews in Urology|January 6, 2018
Management of prostate cancer: NYU Case of the Month, July 2017Samir S Taneja
The Journal of Urology|February 20, 2020
Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (<sup>177</sup>Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate CancerSamir S Taneja
The Journal of Urology|November 13, 2012
Re: Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenibSamir S Taneja
The Urologic Clinics of North America|April 18, 2015
Management of high grade bladder cancer: a multidisciplinary approachSamir S Taneja
The Journal of Urology|March 14, 2015
Re: Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerSamir S Taneja
The Journal of Urology|January 14, 2014
Re: long-term survival of participants in the Prostate Cancer Prevention TrialSamir S Taneja
The Journal of Urology|January 14, 2014
Re: empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trialSamir S Taneja
Pageof 85

Showing results (61-70 of 845) with videos related to

Sort By:
Pageof 85
The Journal of Urology|November 18, 2017
Re: Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerSamir S Taneja
The Journal of Urology|November 18, 2017
Re: Association between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerSamir S Taneja
The Journal of Urology|November 18, 2017
Re: Associations of Luminal and Basal Subtyping of Prostate Cancer with Prognosis and Response to Androgen Deprivation TherapySamir S Taneja
Reviews in Urology|January 6, 2018
Management of prostate cancer: NYU Case of the Month, July 2017Samir S Taneja
The Journal of Urology|February 20, 2020
Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (<sup>177</sup>Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate CancerSamir S Taneja
The Journal of Urology|November 13, 2012
Re: Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenibSamir S Taneja
The Urologic Clinics of North America|April 18, 2015
Management of high grade bladder cancer: a multidisciplinary approachSamir S Taneja
The Journal of Urology|March 14, 2015
Re: Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerSamir S Taneja
The Journal of Urology|January 14, 2014
Re: long-term survival of participants in the Prostate Cancer Prevention TrialSamir S Taneja
The Journal of Urology|January 14, 2014
Re: empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trialSamir S Taneja
Pageof 85